Molecular mechanisms of drug resistance and its reversal in cancer

Area of Science:

• Oncology
• Pharmacology

Background:

• Chemotherapy is a primary cancer treatment, but its efficacy is limited by multidrug resistance (MDR).
• MDR involves tumor cells developing cross-resistance to diverse drugs, stemming from intrinsic or acquired mechanisms.
• This resistance significantly impacts treatment outcomes and patient survival.

Purpose of the Study:

• To review the multifaceted mechanisms underlying multidrug resistance in cancer chemotherapy.
• To explore molecular and biochemical strategies aimed at overcoming or reversing multidrug resistance.

Main Methods:

• Comprehensive literature review of established and emerging MDR mechanisms.
• Analysis of molecular pathways and biochemical processes involved in drug resistance.
• Examination of therapeutic strategies targeting MDR.

Main Results:

• MDR arises from various mechanisms including altered drug transport, target modification, and impaired apoptosis.
• Specific mechanisms include efflux pump overexpression, reduced drug uptake, and aberrant sphingolipid metabolism.
• Numerous molecular and biochemical approaches are being investigated to combat MDR.

Conclusions:

• Elucidating MDR mechanisms is essential for advancing cancer therapy.
• Targeting these resistance pathways offers promising avenues for overcoming treatment failures.
• Further research into reversing MDR is critical for improving patient outcomes.